참고문헌
- 대한의학협회지 v.24 한국정상인 말초혈액 림파구의 Natural Killer(NK)활성치에 관한 연구 하윤문;김광혁;전무형;우종설;임수덕
- Adv Immunol. v.47 Biology of natural killer cells Trincheri G.
- Clin. Immunol. Immunopathol. v.19 Distribution of natural killer activity in peripheral blood, cord blood, thymus, lymph nodes, and spleen and the effect of in vitro with interferon preparation Antonelli P.;Stewart Ⅱ W.;Dupont B.
- Br. J. Cancer v.6 Intensity of class I antigen expression on hyman cell lines and its relevance to the efficiency of non-MHC-restricted killing Nouri A. M. E.;Hussain R. F.;Dos santos A. V. L.
- J. Immunol. Methods. v.180 Super-sensitive eqithelial cell line and colorimetric assay to replace the conventional K562 target and chromium releae assay for assement of non-MHC-restricted cytotoxicity Nouri A. M. E.;Mansorui M.;Hussain R. F.;Dos Santos a. V. L.;Oliver R. T. D.
- Cancer Res. v.48 Effects of systemic recombinant interleukin-2 on natural killer and lymphokine activated killer activity of human tumor infiltrating lymphoctes Anderson T. M.;Ibayashi Y.;Tokida Y.;Colquhoun S. D.;Carmack E.;Colub S. H.
- Immunol. Today v.10 The cytokine network Balkwill F. R.;Burke F.
- Nature v.273 Enhanced NK cell activity in mice injected with interferon and interferon inducers Gidlund M.;Orn A.;Wigzell H.;Senik A.;Gresser I
- J. Exp. Med. v.155 Lymphokine-activated killer cell phenomenon : Lysis of natural killer-resistent fresh solid tumor cells by interleukin 2-activated autologous hyman peripheral blood lymphocytes Grimm E. A.;Mazumder A.;Zhang H. Z.;Rosenberg S. A.
- J. Immunol. v.126 In vitro augmentation of rat natural killer cell activity Reynolds C. W.;Herberman R. B.
- J. Immunol. v.138 Depletion of natural killer cells in mice by monoclonal antibody to NK-1.1 : Reduction in host defence against malignancy without loss of cellular of humoral immunity Seaman W. E.;Sleisenger M.;Eriksson E.;Koo G. C.
- Br. J. Haematol. v.77 Inducibility of lymphokine activated killer(LAK) cells in patients with myelogenous leukemia in complete remission and its clinical relevance Archimbaud E.;Bally M.;Dore J.
- J. Immunol. v.140 Characteristics and mechanism of IFN-gamma-induced protection of human tumor cells from lysis by lymphokine-activated killer cells Fries R. U.;Golub SH
- Cell. Immunol. v.94 The human lymphokine-activated killer cell system : V. Purified recombinant interleukin-2 activated cytotoxic lymphocytes which lyse both natural killer-resistant autologous and tumors and thitrophenyl-modified autologous peripheral blood lymphocytes Grim E. A.;Wilson D. J.
- Toxicol. Appl. Pharmacol. v.116 Evaluation of murine splenic cell type metabolism of benzo(a)pyrene and functionality in vitro following repeated in vivo exposure to benzo(a)pyrene Ladics g. S.;Kawabata T. T.;Munson A. E.;White KL Jr
- Toxicol. v.31 Immunocytotoxicity effects of polycyclic aromatic hydrocarbons on mouse lymphocytes Wojdani A.;Attarzadeh M.;Woldetsadik G.;Alfred LJ
- Cancer Res. v.46 Immunomodulation by polyaromatic hydrocarbons in mice and murine cells Blanton R. H.;Lyte M.;Myers M. J.;Bick P. H.
- Clin. Exp. Immunol. v.52 Selective immunosuppression resulting from exposure to the carcinogenic congener of benzopyrene in B6C3F1 mice Dean J. H.;Luster M. I.;Boorman G. A.;Lauer L. D.;Leubke R. W.;Lawson L.
- J. Natl. Cancer Inst. v.36 Effectsof noncarcinogenic and carcinogenic hydrocarbons on antibody-forming cells measured at the cellular level in vitro Stjernsward J.
- Selected methods in cellular immunology(1st ed.) Mishell B. B.;Shiigi S. M.
- J. Immunol. Methods v.170 Evaluation of the MTT and SRB assays for testing LAK cellmediated growth inhibition of various adherent and non-adherent tumor target cells Garbin F.;Eckert K.;Maurer H. R.
- J. Immunol. Methods v.160 A new approach for measurement of cytotoxicity using colormetric assay Hussain R. F.;Nouri A. M. E.;Oliver R. T. D.
- J. Immunol. Methods v.65 Rapid colorimetric assay for cellular growth and survival : Application to proliferation and cytotoxic assays Mosmann T.
- J. Pharmacol. Exp. Ther. v.242 Mechanisms of benzo(a)pyrene-induced modulation of antigen presentation Myers M. J.;Schook L. B.;Bick P. H.
- Cancer Res. v.44 Direct suppression of in vitro antibody production by mouse spleen cells by the carcinogen benzo(a)pyrene but not the noncarcinogenic congener benzo(a)pyene White K. L.;Holsapple M. P.